Sendegobresib

N/A

Report date: 2025/09/04 10:36:31
NME

Base Information

Drug NameSendegobresib
Drug Alias NameCFT-8634CFT8634
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionBromodomain-containing protein 9 degraders
TargetsBromodomain-containing protein 9
Therapy Area/IndicationsSarcomaSarcoma, Synovial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesC4 Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC4 Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSarcomaSarcoma, Synovial

Other Information

ATC CodeN/A
Related LinksN/A